Single-institution outcome of high-dose interleukin-2 (HD IL-2) therapy for metastatic melanoma and analysis of favorable response in brain metastases. (Q48427915)
Jump to navigation
Jump to search
scientific article published in October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Single-institution outcome of high-dose interleukin-2 (HD IL-2) therapy for metastatic melanoma and analysis of favorable response in brain metastases. |
scientific article published in October 2009 |
Statements
Single-institution outcome of high-dose interleukin-2 (HD IL-2) therapy for metastatic melanoma and analysis of favorable response in brain metastases (English)
Steven Powell
Arkadiusz Z Dudek